This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: Pfizer Corporation, Boston Medical Center Corporation, Repligen Corporation. Active years: 2016-2024.
Company Filing History:
4 out of 4,486 
2 out of 62 
1 out of 132 
Years Active: 2016-2024
Title: The Innovative Mind of Michael Shamashkin
Introduction
Michael Shamashkin, an accomplished inventor based in Woburn, MA, has made significant contributions to the field of biotechnology. His portfolio includes five patents, showcasing his remarkable ability to innovate and develop solutions that advance our understanding of cellular mechanisms and therapeutic applications.
Latest Patents
Among his recent inventions, Shamashkin has developed recombinant Roundabout Receptor 2 (ROBO2) proteins, which are designed to bind SLIT ligands. This innovative invention aims to prevent the binding of these ligands to ROBO2 cell surface receptors, potentially leading to groundbreaking methods and uses in biomedical research and treatment. The details of this patent reflect his commitment to addressing complex biological challenges through advanced technology.
Career Highlights
Michael Shamashkin has built a distinguished career, with significant tenures at reputable institutions such as Pfizer Corporation and Boston Medical Center Corporation. His experience in these organizations has provided him with a robust foundation in both research and practical applications of his innovations, enhancing his impact within the scientific community.
Collaborations
Throughout his career, Shamashkin has collaborated with notable colleagues, including Stephen Berasi and Janet Elizabeth Buhlmann. These partnerships have fostered a dynamic exchange of ideas, contributing to the success of many projects and inventions within the realm of biotechnology.
Conclusion
Michael Shamashkin stands out as a visionary inventor whose work with recombinant ROBO2 proteins reflects not only his technical expertise but also his dedication to improving human health through innovative solutions. His patents and collaborations continue to influence the field, and his contributions will undoubtedly spark further advancements in biotechnology.